Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial.
Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Gugusheff J, Phung N, Montebello M, Chan T, Kirby A, Hall M, Jefferies M, Luksza J, Shanahan M, Kevin R, Allsop D; Agonist Replacement for Cannabis Dependence (ARCD) study group. Lintzeris N, et al. Among authors: hall m. JAMA Intern Med. 2019 Sep 1;179(9):1242-1253. doi: 10.1001/jamainternmed.2019.1993. JAMA Intern Med. 2019. PMID: 31305874 Free PMC article.
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Bhardwaj AK, Allsop DJ, Copeland J, McGregor IS, Dunlop A, Shanahan M, Bruno R, Phung N, Montebello M, Sadler C, Gugusheff J, Jackson M, Luksza J, Lintzeris N; Agonist Replacement for Cannabis Dependence (ARCD) study group. Bhardwaj AK, et al. BMC Psychiatry. 2018 May 18;18(1):140. doi: 10.1186/s12888-018-1682-2. BMC Psychiatry. 2018. PMID: 29776349 Free PMC article.
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial.
Lintzeris N, Mills L, Dunlop A, Copeland J, Mcgregor I, Bruno R, Kirby A, Montebello M, Hall M, Jefferies M, Kevin R, Bhardwaj A; Agonist Replacement For Cannabis Dependence Study Group. (Arc-D). Lintzeris N, et al. Among authors: hall m. Drug Alcohol Depend. 2020 Oct 1;215:108220. doi: 10.1016/j.drugalcdep.2020.108220. Epub 2020 Aug 1. Drug Alcohol Depend. 2020. PMID: 32768992 Clinical Trial.
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
Deacon RM, Mammen K, Bruno R, Mills L, Dunlop A, Holmes J, Jefferies M, Hall M, Shakeshaft A, Farrell M, Graham R, Lintzeris N. Deacon RM, et al. Among authors: hall m. Addiction. 2021 May;116(5):1245-1255. doi: 10.1111/add.15331. Epub 2021 Jan 4. Addiction. 2021. PMID: 33201546
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.
Cunningham EB, Hajarizadeh B, Amin J, Litwin AH, Gane E, Cooper C, Lacombe K, Hellard M, Read P, Powis J, Dalgard O, Bruneau J, Matthews GV, Feld JJ, Dillon JF, Shaw D, Bruggmann P, Conway B, Fraser C, Marks P, Dore GJ, Grebely J; SIMPLIFY and D3FEAT study groups. Cunningham EB, et al. Clin Infect Dis. 2020 Oct 23;71(7):e115-e124. doi: 10.1093/cid/ciz1089. Clin Infect Dis. 2020. PMID: 31677262 Free article.
6,850 results